Navigation Links
Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research
Date:11/9/2009

vioral medicine, and a Post-Doctoral fellowship at the Center for Studies of Addiction at the University of Pennsylvania. Dr. Carise resides in Philadelphia with her husband, A. Thomas McLellan, Ph.D., founder of the Treatment Research Institute and currently Deputy Director of the White House Office of National Drug Control Policy.

She will succeed current CCO Dr. David Deitch, who will continue to support Phoenix House as a consultant on a broad range of strategic issues from January 2010 onwards.

For more information, to speak with Dr. Deni Carise, or for any media inquiries, please contact Karen Sodomick, Director of Marketing and Communications for Phoenix House, at 646-505-2093 or ksodomick@phoenixhouse.org. You may also contact Davia Temin or Allison Bennett of Temin and Company at 212-588-8788 or news@teminandco.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Howard Meitiner | https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=89320

About Phoenix House

Phoenix House is one of the nation's leading non-profit substance abuse prevention and treatment service organizations, serving close to 7,500 men, women (including women with children), and teens each day at more than 150 drug and alcohol treatment and prevention programs in 10 states -- California, Connecticut, Florida, Maine, Massachusetts, New Hampshire, New York, Rhode Island, Texas, and Vermont. For information, visit www.phoenixhouse.org.

SOURCE Phoenix House


'/>"/>
SOURCE Phoenix House
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Partners Rx Chief Pharmacy Officer, Richard Bullard on Panel Discussion at the Fall 2007 Managed Markets Summit (MMS) in Phoenix, AZ.
2. Susan G. Komen for the Cures Phoenix Affiliate, State Officials, Survivors and Advocates Call for Action on Breast Cancer
3. PinnacleHealth System Selects Phoenix Health Systems to Provide HIPAA Security Assessment Services
4. Hospira to Present at the Credit Suisse Phoenix Health Care Conference on November 13
5. Salem Hospital Selects Phoenix Health Systems for Information Technology Infrastructure Management Services
6. Phoenix Health Systems Project Management Office Service Line is Recognized by the Project Management Institute as a Registered Education Provider
7. Phoenix Fire Chief Bob Khan Encourages Arizonans to Get Vaccinated Against Influenza
8. Shengtai Pharmaceutical, Inc. to Present at Roth Capital Phoenix Conference
9. DaVita and Phoenix-Based Southwest Kidney Institute Form Broad Partnership
10. LogistiCare, a Subsidiary of Providence Service Corp., Opens Phoenix Call Center to Support Expanding Commercial Client Base
11. Fortune 100 Companies Share Customer Experience Insights in Phoenix, Ariz., Feb. 25-27

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., , NEW YORK, Nov. 20 Re...h report is available in its catalogue. ,, Onc...t Forecast to 2013 ,, http://www.reportlinke...chmarks-and-Market-Forecast-to-2013.html#utm_sourc...newswire ,, Comprehensive Forecasts and Detai...
(Date:11/20/2009)..., , NEW YORK, Nov. 20 Re...h report is available in its catalogue. ,, Ima...ttp://www.reportlinker.com/p0164325/Imaging-Agents...swire&utm_medium=pr&utm_campaign=prnewswir...nized the visualization of organs within the human...
(Date:11/20/2009)..., , HINESBURG, Vt., Nov. 20 K...mpany that specializes in creating sophisticated m...ay announced the launch www.infectioncontrolsourc...care administrators with a comprehensive database ..., "Our mission at Kestrel is to educate healthcar...
(Date:11/20/2009)..., , LOS ANGELES, Nov. 20 As...al feasts, more than 1.25 million people in Los An...rstand the magnitude of the problem, that,s nearly..., people you see every day are hungry - and the si...continues to increase. ,, The Jewish Federatio...
(Date:11/20/2009)...y molecule identified by researchers , ,...may be moving closer to better treatments for bovi...cow disease, and the related condition called Creu...can-1 is crucial to the development of mad cow dis...erstanding its role could help scientists figure o...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013 2Health News:Reportlinker Adds Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013 3Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 2Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 3Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 4Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 5Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 6Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 7Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 8Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 9Health News:Infection Prevention Online Community Site Launches - Focused on Product Selection 2Health News:The Jewish Federation Unveils Blueprint to End Hunger in Los Angeles 2Health News:The Jewish Federation Unveils Blueprint to End Hunger in Los Angeles 3
...ief that infants' brains don't divide into left-br...study finds the brain's left hemisphere plays the ... beginning almost immediately after birth. Rese...e fMRI has been used to study infants. It is a non...
...osed among men in the United States -- affecting n... treatment options, but new research shows there m... Doctors hope that the drug -- finasteride -- wil... conversion to DHT -- a more active form of the ho...
...ugs used for acute asthma attacks might be causing... studied the use of bronchodilators known as beta-...ry treatment used to relieve acute asthma attacks.... Whatever the mode of administration, they work by...
... blood pressure and heart failure may also benefit...er risk for heart attacks and stroke. Researcher...women from the Heart Outcomes Prevention Evaluatio...ng stroke, peripheral arterial disease, or diabete...
...he risk of dementia , some find light to moderate ... others still find no association at all. In a ... between the ages of 65 and 79 who were followed o...ltogether were both about twice as likely as those...
...ely low body fat whether due to strenuous exercise...from treatment with the appetite-and-weight-regula...ptin may be useful in treating some instances of i...g how much energy is available to the body for imp...
Other Medicine News:Health News:fMRI Offers Insight Into An Infants Brain 2
(Date:11/20/2009)... , PLYMOUTH MEETING, Pa., Nov. 20 /PRNewswire...Times article that questions why currently availa... cancers are being ignored, ECRI Institute, an ind...dmap to the evidence on Finasteride for Preventio...he November 13, 2009, New York Times article, " ...
(Date:11/19/2009)... , ARDEE, Ireland, Nov. 19 Warn...he pricing of its previously announced secondary o...price to the public of $22.25 per share. The sell...n Capital Partners, DLJ Merchant Banking, J.P. Mor...H. Lee Partners, L.P., certain other institutional...
(Date:11/19/2009)... , TAINAN, Taiwan, Nov. 19 /PRNewswire-Asi...ive pharmaceutical ingredients (APIs), announced t...mpound Safety Certification from,SafeBridge(R) Con...rm,s,competency and proficiency in the safe handli...Is), and applies to specific laboratories and,prod...
Breaking Medicine Technology:ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Harold Hank Gardner M D Named in the Future Health 100 56303 1Harold Hank Gardner M D Named in the Future Health 100 56303 2Pharmacists Urge the Public to Begin Getting Immunized 56298 1Pharmacists Urge the Public to Begin Getting Immunized 56298 2Pharmacists Urge the Public to Begin Getting Immunized 56298 3Stand Up for Health Care 21 A Labor Day Message From RWDSU President Stuart Appelbaum 56294 1Stand Up for Health Care 21 A Labor Day Message From RWDSU President Stuart Appelbaum 56294 2Stand Up for Health Care 21 A Labor Day Message From RWDSU President Stuart Appelbaum 56294 3
...ive Phase 2a Trial, WALTHAM, Mass., June 12 Repl...that based on feedback from the Food and,Drug Admi...2b clinical,trial of RG2417, an oral formulation o... this year. This will be a multi-center, parallel ...proximately 150 patients with,bipolar disorder wil...
...vement in disease activity through three yea...crease in adverse events, malignancies, infections... over time -, ROCKVILLE, Md., June 12 Human Geno... the presentation of results,from a long- term Pha...R),(belimumab) was associated with sustained impro...
Other Medicine Technology:Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder 2Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder 3Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder 4Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder 5Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus 2Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus 3Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus 4Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus 5Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus 6Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus 7
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
Medicine Products: